Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Scientists discover new option for treating malignant pleural mesothelioma

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma.

24 Oct 2016

Natural compound isolated from onions contains anti-ovarian cancer properties, research finds

Research from Kumamoto University, Japan has found that a natural compound isolated from onions, onionin A (ONA), has several anti-ovarian cancer properties.

20 Oct 2016

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease.

19 Oct 2016

Financial difficulties may impact treatment outcomes for cancer patients

Financial difficulties can significantly impact a cancer patient's quality of life during treatment and may even increase their risk of death, according to the results of a pooled analysis presented at the ESMO 2016 Congress in Copenhagen.

12 Oct 2016

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first time at the ESMO 2016 Congress in Copenhagen and published in the New England Journal of Medicine.

8 Oct 2016

Unique partnership develops web-based resource addressing issues in gynecologic cancers

In order to help families benefit from precision medicine, several professional medical organizations and patient advocacy groups have collaborated to develop a resource for healthcare providers and patients concerned with gynecologic cancers.

5 Oct 2016

HDAC inhibitors show potential to eliminate breast and ovarian cancer stem cells

A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).

4 Oct 2016

Research shows how new ovarian cancer treatment could help boost anti-tumor immunity

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.

3 Oct 2016

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat.

29 Sep 2016

Study suggests ovary removal to prevent ovarian cancer should be discontinued in premenopausal women

A Mayo Clinic research team has found evidence suggesting that the controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be discontinued in women who are not at high risk of cancer.

29 Sep 2016

Super-Resolution Imaging of Biological Specimens

In this interview, News Medical speaks to Dr. Manasa Gudheti of Bruker Nano Surfaces about biological specimens and how to acquire super-resolution images of them.

From Bruker Nano Surfaces and Metrology 27 Sep 2016

British Lung Foundation announces funding for IPF research

Britons are officially three times more likely to die of the incurable lung condition idiopathic pulmonary fibrosis (IPF), than in a road accident. Despite this, the disease is so unheard of and underfunded in research doctors still don’t know what causes it.

From Asthma + Lung UK 24 Sep 2016

Diet high in calcium, low in lactose may decrease risk of ovarian cancer in African-American women

Research from Rutgers Cancer Institute of New Jersey and and other U.S. health and academic institutions shows a diet high in calcium and low in lactose may reduce the risk of ovarian cancer in African-American women.

16 Sep 2016

BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

Few effective treatments have been approved to treat ovarian cancer, the deadliest of all cancers affecting the female reproductive system.

14 Sep 2016

Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

Individual cells within a tumor are not all the same. This may sound like a modern medical truism, but it wasn't very long ago that oncologists assumed that taking a single biopsy from a patient's tumor would be an accurate reflection of the physiological and genetic make-up of the entire mass.

9 Sep 2016

New drug holds potential for treating advanced mastocytosis

Most people have never heard of mastocytosis. It's a rare, sometimes deadly, immune disorder. Now new research may help those with advanced mastocytosis and possibly many more people, too.

6 Sep 2016

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union and, though to a smaller degree, in Japan by 2020, according to new research published in the leading cancer journal Annals of Oncology today (Tuesday).

5 Sep 2016

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors.

5 Sep 2016

New NCCN Imaging AUC released for eight new cancers

The National Comprehensive Cancer Network, a Centers for Medicare & Medicaid Services-approved provider-led entity for imaging appropriate use criteria, continues to build its library of AUC and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types. Launched in June 2016, NCCN Imaging AUC currently are available for 20 cancer types.

29 Aug 2016

New drug delivery system slows and controls tumors not aiming for complete elimination

Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment - to dramatically slow and control tumors on a long-term, sustained basis, not necessarily aiming for their complete elimination.

26 Aug 2016

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Scientists discover new option for treating malignant pleural mesothelioma

Natural compound isolated from onions contains anti-ovarian cancer properties, research finds

Research could lead to new type of treatment for pancreatic cancer based on gold nanoparticles

Financial difficulties may impact treatment outcomes for cancer patients

PARP inhibitor prolongs progression-free survival in patients with recurrent ovarian cancer

Unique partnership develops web-based resource addressing issues in gynecologic cancers

HDAC inhibitors show potential to eliminate breast and ovarian cancer stem cells

Research shows how new ovarian cancer treatment could help boost anti-tumor immunity

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Study suggests ovary removal to prevent ovarian cancer should be discontinued in premenopausal women

Super-Resolution Imaging of Biological Specimens

British Lung Foundation announces funding for IPF research

Diet high in calcium, low in lactose may decrease risk of ovarian cancer in African-American women

BET inhibitors could be powerful new therapeutic strategy for ovarian cancer

Penn researchers develop open-source software to infer evolutionary track of tumor metastasis

New drug holds potential for treating advanced mastocytosis

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

New NCCN Imaging AUC released for eight new cancers

New drug delivery system slows and controls tumors not aiming for complete elimination

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in